We consider that the combination of siRNA for the driver gene PTBP1 and the miR-145 silencing of the plural genes associated with the networks related to PTBP1 expression, such as c-Myc and PI3K/AKT signaling molecules, could avoid drug resistance of various kinds of cancers (Scheme 1). The gene discussed is PTBP1; the disease is cancer.